Conference Proceedings

Tubular protection with empagliflozin treatment in subjects with type 2 diabetes and cardiovascular disease: a sub-analysis of the EMPA-HEART CardioLink-6 trial

E Opingari, S Verma, CD Mazer, KA Connelly, AT Yan, F Zuo, T Mason, B Chowdhury, Y Pan, A Quan, H Teoh, LA Leiter, B Zinman, DZI Cherney, RE Gilbert

DIABETOLOGIA | SPRINGER | Published : 2019


Funding Acknowledgements

Supported by: Boehringer Ingelheim